Abstract
Purpose: Serial diffusion‐weighted MRI (DW‐MRI) measurements of the apparent diffusion coefficient (ADC) of rectal tumors are used for rectal cancer response evaluation after neo‐adjuvant treatment. In this study, we determined the repeatability of DW‐MRI to distinguish therapy‐related response from measurement variations.Materials and Methods: In 18 patients with rectal cancer on five consecutive days, 1.5 Tesla (T) MR imaging was performed including two identical DW‐MRI sequences. The repeatability of the tumor ADC measurements and the intraobserver ADC variation were depicted in a Bland‐Altman plot. The repeatability coefficient was calculated as the range of ADC values of two identical DWI measurements for 95% of subjects. It was expressed as percentage of the mean ADC value.Results: Three females and 15 males were included. The mean tumor ADC value was 1.15 × 10−3 mm2/s (SD 0.07 × 10−3 mm2). The repeatability coefficient of the ADC value was 9.8% and for the intraobserver repeatability 4.7%.Conclusion: In serial DW‐MRI for rectal cancer treatment response evaluation, a repeatability coefficient of 9.8% has to be considered to account for measurement variations in rectal tumor ADC. These variations represent observer judgement and patient and MR spectrometer induced variations. J. Magn. Reson. Imaging 2014;40:146–150. © 2013 Wiley Periodicals, Inc.

This publication has 24 references indexed in Scilit: